Orchestra BioMed Holdings Inc
OBIO
Get informed when a big investor buys or sells
+ FollowMarket Cap$250.9M
Close$
$-0.01
100.2% downside
Current Fair Value
100.2% downsideOvervalued by 100.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $250.90 Million |
|---|---|
| Enterprise Value | $224.05 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.38 |
| Beta | 0.5 |
| Outstanding Shares | 38,392,716 |
Return
| Return on Equity | -107.70% |
|---|---|
| Return on Assets | -54.53% |
| Return on Invested Capital | -63.20% |
Valuation & Multiples
| P/E Ratio | -2.95 |
|---|---|
| PEG | -28.58 |
| Price to Sales | - |
| Price to Book Ratio | 4.19 |
| Enterprise Value to Revenue | 6.85 |
| Enterprise Value to EBIT | -4.08 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 18, 2026
EPS Estimate
$-0.42
Average shareholder expectationRevenue Estimate
$1.03 M
Average shareholder expectationNext Earnings Call
Expected Date
August 11, 2026
EPS Estimate
$-0.35
Average shareholder expectationRevenue Estimate
$137,714
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 43.57% |
|---|---|
| Total Calls | 15,300▼ 59.84% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 60.15%▲ 3.63% |
|---|---|
| Total Invested | $98.19M▲ 9.02% |
| Investors Holding | 660% |
ESG Score
No data
About Orchestra BioMed Holdings Inc
4 employees